Published in Healthcare Finance, Tax and Law Weekly, June 10th, 2009
Almost twenty years after discovering a new chemical compound that affects neurological systems, Harold Kohn, Ph.D., University of North Carolina at Chapel Hill, inventor of the recently FDA-approved Vimpat(R) (lacosamide)C-V, meets Veronica Crowe, whose life has changed significantly with the use of the drug. Dr. Kohn was moved to hear her story of perseverance, and Veronica was thrilled to thank the man whose discovery helped her achieve greater seizure control. Vimpat is now available as an add-on therapy for the treatment of partial-onset seizures in adults 17 years and older with epilepsy.
The approval of Vimpat...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.